C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2006
11/23/2006	WO2006044732A3 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
11/23/2006	WO2006029154A3 Novel compounds
11/23/2006	WO2005112932A3 Raf modulators and methods of use
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264637 Preparation of paroxetine hydrochloride hemihydrate
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264496 Substituted indoline and indole derivatives
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264476 Substituted imidazoles and thiazoles; 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl)methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile, antitumor agents
11/23/2006	US20060264471 3-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derviatives and use thereof as medicines for treating schizophrenia
11/23/2006	US20060264440 Pyrazoles and methods of making and using the same
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264419 Substituted pyrazoles
11/23/2006	US20060264417 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease
11/23/2006	US20060263841 Nitropyrimidine derivative for detection and evaluation of kinase inhibitors
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	DE102005023207A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
11/23/2006	CA2609900A1 Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth
11/23/2006	CA2609288A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2608419A1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	CA2606774A1 Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
11/23/2006	CA2605272A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
11/23/2006	CA2605050A1 Histone deacetylase inhibitors
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724263A1 Basic amine compound and use thereof
11/22/2006	EP1724259A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indazol-5-yl)-octan amide derivatives and related compounds as renin inhibitors for the treatment of hypertension
11/22/2006	EP1724256A2 Novel process for the synthesis of 5-(4-fluorphenyl)-1-2(2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
11/22/2006	EP1723954A1 Indazole derivatives for the treatment of cancer
11/22/2006	EP1723208A1 Reversible piezochromic systems
11/22/2006	EP1723143A2 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
11/22/2006	EP1723140A1 Process for the preparation of tryptase inhibitors
11/22/2006	EP1723132A1 Ep2 receptor agonists
11/22/2006	EP1723123A1 Ion channel modulators
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1723121A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
11/22/2006	EP1723111A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006	EP1723108A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006	EP1723105A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
11/22/2006	EP1722798A1 Pyrimidine compounds as purine receptor antagonist
11/22/2006	EP1722783A2 Ion channel modulators
11/22/2006	EP1501815B1 Substituted phenylacetamides and their use as glucokinase activators
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
11/22/2006	EP1343765B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1311272B1 Novel methods using cholinesterase inhibitors
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1244651B1 Diamidine compounds as dna minor groove binders
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867565A Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes
11/22/2006	CN1867564A Process for preparing amino crotonyl compounds
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006	CN1285590C Itraconazole hydrochloride oral solid composition and preparation method
11/22/2006	CN1285588C Farnesyl protein transferase inhibitors
11/22/2006	CN1285581C Process for preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
11/21/2006	US7138523 Reacting arecoline or derivative with 4-fluorophenylmagnesium halide Grignard reagent in a solvent (free of diethyl ether solvent)
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138392 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
11/21/2006	US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/21/2006	CA2168022C Vasoconstrictive substituted dihydropyranopyridines
11/21/2006	CA2158060C Process for the preparation of .beta.-phenylisoserine derivatives
11/20/2006	CA2547186A1 Novel biochalcophenes and their prodrugs as antiprotozoal agents
11/18/2006	CA2547251A1 Fused pyrazolyl compounds for cancer treatment
11/16/2006	WO2006121856A2 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
11/16/2006	WO2006121218A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	WO2006121106A1 Method for producing indole derivative having piperidine ring
11/16/2006	WO2006121104A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006	WO2006121097A1 Bicyclic heterocyclic derivative or salt thereof
11/16/2006	WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	WO2006120224A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	WO2006076415A3 Exo- and diastereo- selective syntheses of himbacine analogs
11/16/2006	WO2006000589A8 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	US20060258710 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
11/16/2006	US20060258693 Halogenated quinazolinyl nitrofurans as antibacterial agents
11/16/2006	US20060258682 Benzofuran compounds
11/16/2006	US20060258680 Chromenoneindoles
11/16/2006	US20060258666 c-fms kinase inhibitors
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/16/2006	US20060258641 Methods and compositions of novel triazine compounds
11/16/2006	US20060258638 Succinoylamino lactams as inhibitors of A-beta protein production
11/16/2006	US20060258614 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
11/16/2006	US20060257917 Fluorescent dyes, energy transfer couples and methods
11/16/2006	DE10228857B4 Tetraetherlipide mit kleinen Kopfgruppen, deren Herstellung und Verwendung Tetraether lipids with small head groups, their preparation and use
11/16/2006	CA2608184A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	CA2607939A1 Process for production of 4-biphenylyazetidin-2-ones
11/16/2006	CA2607917A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives

1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 694